Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference72 articles.
1. Aronson JK. Distinguishing hazards and harms, adverse drug effects and adverse drug reactions: implications for drug development, clinical trials, pharmacovigilance, biomarkers, and monitoring. Drug Saf. 2013;36:147–53.
2. Shepherd G, Mohorn P, Yacoub K, May DW. Adverse drug reaction deaths reported in United States vital statistics, 1999–2006. Ann Pharmacother. 2012;46:169–75.
3. Suh DC, Woodall BS, Shin SK, Hermes-De Santis ER. Clinical and economic impact of adverse drug reactions in hospitalized patients. Ann Pharmacother. 2000;34:1373–9.
4. Agency for Healthcare Research and Quality. Reducing and preventing adverse drug events to decrease hospital costs. AHRQ Archive.
https://archive.ahrq.gov/research/findings/factsheets/errors-safety/aderia/ade.html
. Accessed 2 Apr 2014.
5. Ninan B, Wertheimer A. Withdrawing drugs in the U.S. versus other countries. Innov Pharm. 2012;3(3):Article 87.
https://pubs.lib.umn.edu/index.php/innovations/article/view/269/263
. Accessed 19 Apr 2018.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献